Janssen EA - Search Results

1

Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.

Page DB, Broeckx G, Jahangir CA, Verbandt S, Gupta RR, Thagaard J, Khiroya R, Kos Z, Abduljabbar K, Acosta Haab G, Acs B, Akturk G, Almeida JS, Alvarado-Cabrero I, Azmoudeh-Ardalan F, Badve S, Baharun NB, Bellolio ER, Bheemaraju V, Blenman KR, Botinelly Mendonça Fujimoto L, Bouchmaa N, Burgues O, Cheang MCU, Ciompi F, Cooper LA, Coosemans A, Corredor G, Dantas Portela FL, Deman F, Demaria S, Dudgeon SN, Elghazawy M, Ely S, Fernandez-Martín C, Fineberg S, Fox SB, Gallagher WM, Giltnane JM, Gnjatic S, Gonzalez-Ericsson PI, Grigoriadis A, Halama N, Hanna MG, Harbhajanka A, Hardas A, Hart SN, Hartman J, Hewitt S, Hida AI, Horlings HM, Husain Z, Hytopoulos E, Irshad S, Janssen EA, Kahila M, Kataoka TR, Kawaguchi K, Kharidehal D, Khramtsov AI, Kiraz U, Kirtani P, Kodach LL, Korski K, Kovács A, Laenkholm AV, Lang-Schwarz C, Larsimont D, Lennerz JK, Lerousseau M, Li X, Ly A, Madabhushi A, Maley SK, Manur Narasimhamurthy V, Marks DK, McDonald ES, Mehrotra R, Michiels S, Minhas FUAA, Mittal S, Moore DA, Mushtaq S, Nighat H, Papathomas T, Penault-Llorca F, Perera RD, Pinard CJ, Pinto-Cardenas JC, Pruneri G, Pusztai L, Rahman A, Rajpoot NM, Rapoport BL, Rau TT, Reis-Filho JS, Ribeiro J… See abstract for full author list ➔ Page DB, et al. Among authors: janssen ea. J Pathol. 2023 Aug;260(5):514-532. doi: 10.1002/path.6165. Epub 2023 Aug 23. J Pathol. 2023. PMID: 37608771 Free PMC article. Review.

2

In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.

Janssen EA, Baak JP, Guervós MA, van Diest PJ, Jiwa M, Hermsen MA. Janssen EA, et al. J Pathol. 2003 Dec;201(4):555-61. doi: 10.1002/path.1475. J Pathol. 2003. PMID: 14648658

3

Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node-negative breast cancer patients younger than 55 years.

Baak JP, van Diest PJ, Voorhorst FJ, van der Wall E, Beex LV, Vermorken JB, Janssen EA. Baak JP, et al. Among authors: janssen ea. J Clin Oncol. 2005 Sep 1;23(25):5993-6001. doi: 10.1200/JCO.2005.05.511. J Clin Oncol. 2005. PMID: 16135467

4

The prognostic value of proliferation in lymph-node-negative breast cancer patients is age dependent.

Baak JP, van Diest PJ, Voorhorst FJ, van der Wall E, Beex LV, Vermorken JB, Janssen EA, Gudlaugsson E; other collaborators of the Multicenter Morphometric Mammary Carcinoma Project (MMMCP). Baak JP, et al. Among authors: janssen ea. Eur J Cancer. 2007 Feb;43(3):527-35. doi: 10.1016/j.ejca.2006.10.001. Epub 2006 Nov 15. Eur J Cancer. 2007. PMID: 17110097

5

Success predictors of adjuvant chemotherapy in node-negative breast cancer patients under 55 years.

Janssen EA, van Diest PJ, Søiland H, Gudlaugson E, Nysted A, Voorhorst FJ, Vermorken JB, Søreide JA, Baak JP. Janssen EA, et al. Cell Oncol. 2006;28(5-6):295-303. doi: 10.1155/2006/152341. Cell Oncol. 2006. PMID: 17167182 Free PMC article.

6

Prognostic differences of World Health Organization-assessed mitotic activity index and mitotic impression by quick scanning in invasive ductal breast cancer patients younger than 55 years.

Skaland I, van Diest PJ, Janssen EA, Gudlaugsson E, Baak JP. Skaland I, et al. Among authors: janssen ea. Hum Pathol. 2008 Apr;39(4):584-90. doi: 10.1016/j.humpath.2007.08.016. Epub 2008 Mar 4. Hum Pathol. 2008. PMID: 18291440

7

Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer.

Gudlaugsson E, Skaland I, Janssen EA, van Diest PJ, Voorhorst FJ, Kjellevold K, zur Hausen A, Baak JP. Gudlaugsson E, et al. Among authors: janssen ea. Breast Cancer Res Treat. 2010 May;121(1):35-40. doi: 10.1007/s10549-009-0442-x. Epub 2009 Jul 1. Breast Cancer Res Treat. 2010. PMID: 19568929

8

In patients younger than age 55 years with lymph node-negative breast cancer, proliferation by mitotic activity index is prognostically superior to adjuvant!

Lende TH, Janssen EA, Gudlaugsson E, Voorhorst F, Smaaland R, van Diest P, Søiland H, Baak JP. Lende TH, et al. Among authors: janssen ea. J Clin Oncol. 2011 Mar 1;29(7):852-8. doi: 10.1200/JCO.2009.25.0407. Epub 2010 Dec 28. J Clin Oncol. 2011. PMID: 21189388

9

Distinct Gene Expression Profiles of Matched Primary and Metastatic Triple-Negative Breast Cancers.

Kaur J, Chandrashekar DS, Varga Z, Sobottka B, Janssen E, Kowalski J, Kiraz U, Varambally S, Aneja R. Kaur J, et al. Cancers (Basel). 2022 May 16;14(10):2447. doi: 10.3390/cancers14102447. Cancers (Basel). 2022. PMID: 35626050 Free PMC article.

10

A spatial attention guided deep learning system for prediction of pathological complete response using breast cancer histopathology images.

Duanmu H, Bhattarai S, Li H, Shi Z, Wang F, Teodoro G, Gogineni K, Subhedar P, Kiraz U, Janssen EAM, Aneja R, Kong J. Duanmu H, et al. Bioinformatics. 2022 Sep 30;38(19):4605-4612. doi: 10.1093/bioinformatics/btac558. Bioinformatics. 2022. PMID: 35962988 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters